ICE vs SRNE · P/E 37, rev $7.28B vs $385.9K cap
Intercontinental Exchange Inc (ICE) versus Sorrento Therape (SRNE) — a side-by-side from cached financials, not a winner call.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
Sorrento Therape (SRNE) is a biotechnology company listed on OTCQB.
Latest reported ICE revenue for 2026-06-30 was $7.28B. Net income was $2.37B. Revenue was up 98.5% from 2026-03-31 to 2026-06-30. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
SRNE does not have a complete income-statement cache yet.
ICE currently screens at market cap $103.55B and trailing P/E 37.3. SRNE currently screens at market cap $385.9K.
Not investment advice. Open the ICE and SRNE stock pages for the full models.
Not investment advice.